Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  dacarbazine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 328 for your search:
Start Over
Phase II-III Chemotherapy with BLEO/DTIC/VBL/ADR/PRED or NM/VCR/PCB/PRED Plus Radiotherapy for Advanced Hodgkin's Disease
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: DFCI-75100
Phase II/III Chemotherapy with SZC/5-FU vs ADR/5-FU for Unresectable Carcinoid Tumors, with DTIC for Failures (Summary Last Modified 07/89)
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-1281
Phase II/III Randomized Comparison of DTIC/BCNU/CDDP vs DTIC/BCNU/CDDP/TMX vs CDDP/TMX in Patients with Disseminated Malignant Melanoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: UCSD-88612, NCI-V89-0023
High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: IIL-HD0801, EudracT Number 2008-002684-14, NCT00784537
Phase III Randomized Study of Standard-Dose MAID (Mesna/DOX/IFF/DTIC) vs Dose-Intensified MAID with G-CSF for Advanced Adult Soft Tissue Sarcoma (Summary Last Modified 12/97)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor:
Protocol IDs: FRE-FNCLCC-PALSAR-93, NCI-F94-0018
Phase III Pilot Study of Alternating Courses of MOPP and ABDV plus Radiotherapy with or without Levamisole for Advanced Hodgkin's Disease
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-75104
Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 10 to 70
Sponsor: NCI, Other
Protocol IDs: ID95-196, P30CA016672, MDA-ID-95196, MDA-DM-95196, NCI-G96-1089, CDR0000065188, NCT00002882
Phase III Randomized Study of Dacarbazine With or Without Allovectin-7 in Patients With Stage III or IV Melanoma (Summary Last Modified 05/2002)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: VCL-1005-301, NCT00003647
Phase III Randomized Study of Adjuvant Chemotherapy in Patients with Refractory or Recurrent Soft Tissue Sarcoma (Summary Last Modified 08/1999)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor:
Protocol IDs: FRE-FNCLCC-96001, EU-98028
S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: S0008, U10CA032102, CALGB-500002, ECOG-S0008, COG-S0008, SWOG-S0008, NCT00006237
Phase III Chemotherapy with CTX/ADR/MTX with or without Alternating ACT-D/DTIC/VCR for Metastatic Sarcomas
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: SEG-356
Phase III Induction and Consolidation Chemotherapy with CTX vs CTX/ADR/DTIC with or without VCR/HU/MTX for Small Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-357
Phase III Chemotherapy with Cyclophosphamide & DTIC with or without Immunotherapy with Corynebacterium Parvum for Metastatic Melanoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-361
Phase III Chemotherapy with BCNU/CTX/VBL/PCB/PRED/BLEO Alternating with ADR/DTIC/BLEO for Hodgkin's Disease
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-75HD301, SEG-366, SEG-75HD0103
Phase III Adjuvant Chemotherapy with CTX/ADR/DTIC plus Radiotherapy for Undifferentiated Small Cell Lung Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-76LUN0103, SEG-365
Phase III Comparison of DTIC/CTX/C. parvum vs C. parvum Alone as Adjuvant Therapy for Stage II-III Melanoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: 14 to 75
Sponsor:
Protocol IDs: SEG-77MEL315, SEG-77MEL0403
Phase III Combination Chemotherapy with BHD (BCNU/DTIC/HU) vs BHD-V (BCNU/DTIC/HU/VCR) for Disseminated Malignant Melanoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7216
Start Over